Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous Doses of ABBV-701 in Healthy Adult Western and Asian Participants

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895343) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous Doses of ABBV-701 in Healthy Adult Western and Asian Participants' on March 20.

Brief Summary: The main objective of this study is to assess the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous (SC) ABBV-701 in healthy adult western and Asian participants.

Study Start Date: March 25

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-701

Subcutaneous

DRUG: Placebo

Subcutaneous

Recruitment Status: RECRUITING

Sponsor: AbbVie

Published by HT Digital Conte...